๐Ÿ“ก TrialPulse
ACTIVE NOT RECRUITINGPHASE3

A Phase 3 Clinical Study of QL2106 Injection

NCT07511647ยทQilu Pharmaceutical Co., Ltd.ยทsource: ClinicalTrials.gov โ†—ยทupdated 2026-10-19
Registry history
Events detected for this trial โ€” severity ร— confidence ร— recency
Neon
How to read the confidence score: 1.0 = observed โ€” the registry record itself changed (a fact). <1.0 (e.g. 0.7) = signal โ€” inferred by a heuristic rule from the data; it flags something worth a look, it is not a confirmed finding. Values below are shown raw from the database; the highlighted parts are the actual values, dimmed parts are JSON syntax.
trial seenhigh2026-10-19
null โ†’ {"status":"ACTIVE_NOT_RECRUITING","last_update_posted_at":"2026-10-19"}
Key dates
Start2026-05-27
Primary completion2027-12-30
Enrollment318estimated
Plaque PsoriasisDRUG
Site map
Per-site markers colored by site status
Live map
unknownJining No.1 People's HospitalJining, China